Emergent BioSolutions (EBS) Liabilities from Discontinued Operations (2015 - 2025)

Emergent BioSolutions' Liabilities from Discontinued Operations history runs 4 years deep, the most recent figure standing at 4500000.0 for Q3 2025.

• In Q3 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 4500000.0; the TTM figure through Sep 2025 stood at 4500000.0 (changed N/A YoY), while the FY2015 annual figure was 17348000.0, changed N/A from the prior year.
• Liabilities from Discontinued Operations was 4500000.0 for Q3 2025 at Emergent BioSolutions, down from 4700000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 37500000.0 in Q1 2023 to a low of 4500000.0 in Q3 2025.
• Historically, Liabilities from Discontinued Operations has averaged 12320000.0 across 3 years, with a median of 4800000.0 in 2025.
• Biggest YoY gain for Liabilities from Discontinued Operations was 53.47% in 2025; the steepest drop was 53.47% in 2025.
• A 3-year view of Liabilities from Discontinued Operations shows it stood at 37500000.0 in 2023, then sank by 73.07% to 10100000.0 in 2024, then tumbled by 55.45% to 4500000.0 in 2025.
• The last three Liabilities from Discontinued Operations figures came in at 4500000.0 (Q3 2025), 4700000.0 (Q2 2025), and 4800000.0 (Q1 2025), per Business Quant data.